SEC Form 4 · accession 0001209191-16-138293
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Ryan
Officer — Chief Financial Officer
Period of report
Aug 19, 2016
Accepted (ET)
Aug 23, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2016 | S | 8,863 | $23.91 | D | 61,148 | D | |
| Common Stock | Aug 19, 2016 | M | 5,000 | $7.12 | A | 66,148 | D | |
| Common StockF2 | Aug 19, 2016 | S | 5,000 | $23.94 | D | 61,148 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| stock option (right to buy)F3 | $7.12 | Aug 19, 2016 | M | 5,000 | A | — | May 21, 2023 | common stock | 5,000 | 15,250 | D |
Explanation of responses
- F1The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.59 to $24.11, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- F2The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.58 to $24.15, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- F3This option was granted on May 21, 2013 and vests in equal quarterly installments over a four-year period beginning on April 1, 2014.